Pharma Mar (LTS:0RC6) Short-Term Debt : €9.9 Mil (As of Mar. 2025)

View and export this data going back to 2011. Start your Free Trial

What is Pharma Mar Short-Term Debt?

Pharma Mar's Short-Term Debt for the quarter that ended in Mar. 2025 was €9.9 Mil.

Pharma Mar's quarterly Short-Term Debt declined from Sep. 2024 (€9.9 Mil) to Dec. 2024 (€8.0 Mil) but then increased from Dec. 2024 (€8.0 Mil) to Mar. 2025 (€9.9 Mil).

Pharma Mar's annual Short-Term Debt declined from Dec. 2022 (€13.1 Mil) to Dec. 2023 (€12.8 Mil) and declined from Dec. 2023 (€12.8 Mil) to Dec. 2024 (€8.0 Mil).

Pharma Mar Short-Term Debt Historical Data

The historical data trend for Pharma Mar's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharma Mar Short-Term Debt Chart

Pharma Mar Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Short-Term Debt

Get a 7-Day Free Trial

15.31

12.21

13.13

12.83

7.97

Pharma Mar Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Short-Term Debt	Get a 7-Day Free Trial															10.92	10.32	9.86	7.97	9.92

Pharma Mar Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Pharma Mar Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Pharma Mar's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharma Mar Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharma Mar SA (LTS:0RC6) » Definitions » Short-Term Debt

Comparable Companies

Traded in Other Exchanges

PHMMF:USA PHMe:UK PHM:Spain PMRA:Germany PHM:Austria

Address

Avenida de los Reyes, 1, Poligono Industrial La Mina-norte, Colmenar Viejo, Madrid, ESP, 28770

Website

http://www.pharmamar.com

Pharma Mar SA is engaged in the research, development, production, and commercialization of bio-active principles of marine origin for application in oncology. It also produces and markets insecticides and air fresheners for household use, household products, wood treatment and decoration products, paints, and similar products. Its operating business segments are Oncology and RNAi. The company obtains its revenues from two main areas: biopharmaceuticals and consumer chemicals, but the biopharmaceuticals is the main line of business.

Pharma Mar Headlines

No Headlines